EYLER CHARLES R 4
4 · PUMA BIOTECHNOLOGY, INC. · Filed Jan 4, 2019
Insider Transaction Report
Form 4
EYLER CHARLES R
SR. VP-FINANCE & TREASURER
Transactions
- Sale
COMMON STOCK
2019-01-03$20.67/sh−1,210$25,011→ 32,757 total
Footnotes (1)
- [F1]The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units.